ArticleBiomedical optics express2025
Perceptual cost and benefit of presbyopia-correcting intraocular lenses: effect of energy balance, addition, and adaptation.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Introduction to the feature Issue "Improving Vision through Intraocular Lenses": a tribute to Jim Schwiegerling.Biomedical optics express · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Presbyopic intraocular lenses (IOLs) based on simultaneous vision represent a compromise between perceptual benefit and cost at near and far distances. We evaluated this compromise for simulated bifocal IOLs with varying energy distributions and additions using SimVis Gekko under different adaptation conditions. Presenting multifocal corrections after a blur adaptation with an abrupt transition of at least 5s improves acceptance. Smooth transitions to multifocality of at least 5s also improve acceptance, independently of previous adaptation. Corrections with low additions show more visual degradation at far without equivalent benefit at near. These results can be useful for IOL designers and clinicians to maximize multifocal adoption of IOLs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.